Is the Pilbara Minerals share price in the buy zone after today's scoping study results?

The Pilbara Minerals Ltd (ASX:PLS) share price has pushed higher after the lithium miner released its Stage 3 Scoping Study results. Should you invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pilbara Minerals Ltd (ASX: PLS) share price is on course to finish the day with a gain.

In afternoon trade the lithium miner's shares are up 1.5% to 68.5 cents following the release of an update on its Stage 3 Scoping Study.

What did the study find?

According to the release, the Stage 3 Scoping Study demonstrates the Pilgangoora project's significant scale, long life, high-quality products and expected low-cost of operations.

Management advised that this supports its continued expansion pathway and Pilbara Minerals' downstream participation strategy.

The study found that the project has "exceptional economics". It has a post-tax NPV 10% of A$3.73 billion, life of mine (LOM) project revenue of A$16.6 billion and LOM project EBITDA of A$10.3 billion. This is based on underlying spodumene pricing developed from revised lithium chemicals' forward price forecasts provided by Roskill.

It also found that it would result in a substantial increase in processing capacity to 7.5Mtpa to deliver average annual production of approximately 1.2Mtpa of SC6.0 spodumene concentrate and approximately 1.1Mlbspa of 30% tantalite concentrate over a mine life of 15 years.

And finally, the study found that the Stage 3 expansion would have competitive LOM operating costs of approximately US$291/tonne CIF.

The company's managing director and CEO, Ken Brinsden, was delighted with the results of the study.

He said: "The Stage 3 Scoping Study has delivered exceptional results which further reinforce the Pilgangoora Project's outstanding quality and scale. The ability to expand the Project to a production rate of well over 1Mtpa of spodumene concentrate, with a minimum mine life of 15 years, underlines our position as a globally significant lithium raw materials producer. At the same time, we believe there is excellent potential to grow the mine life beyond 15 years."

Mr Brinsden was also very optimistic on the company's long term prospects thanks to the electric vehicle and battery storage booms.

He added: "The opportunity in front of us has never been more apparent. As the electric vehicle and battery storage sector grows, so does the opportunity for Pilbara Minerals to become a player in the lithium raw materials supply chain. Together these projects diversify our entrance into this growing market and play directly into our downstream value-adding strategy."

Should you invest?

Whilst I think that Pilbara Minerals has a quality asset on its hands, I feel the success of an investment in the company will ultimately come down to where lithium prices go over the next few years.

Prices have come under significant pressure over the last 12 months due to increasing supply and falling demand. This has unfortunately led to sharp declines in the shares of Pilbara Minerals and lithium peers such as Galaxy Resources Limited (ASX: GXY) and Orocobre Limited (ASX: ORE).

Unfortunately, lithium prices have continued to weaken in 2019. As a result, I would suggest investors hold off an investment in the industry until prices reach an inflection point.

Until then I would gain exposure to the resources sector through miners such as BHP Group Ltd (ASX: BHP) or Rio Tinto Limited (ASX: RIO)

Motley Fool contributor James Mickleboro owns shares of Galaxy Resources Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »